TWEAK in inclusion-body myositis muscle: Possible pathogenic role of a cytokine inhibiting myogenesis

American Journal of Pathology

Volumn 180, Issue 4, 2012, Pages 1603-1613

  Morosetti, Roberta ^a   Gliubizzi, Carla ^a   Sancricca, Cristina ^b   Broccolini, Aldobrando ^a   Gidaro, Teresa ^a   Lucchini, Matteo ^a   Mirabella, Massimiliano ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR INDUCIBLE 14; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR LIKE WEAK INDUCER OF APOPTOSIS; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DERMATOMYOSITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INCLUSION BODY MYOSITIS; MALE; MESOANGIOBLAST; MUSCLE BIOPSY; MUSCLE DEVELOPMENT; POLYMYOSITIS; PRIORITY JOURNAL; PROGRESSIVE MUSCULAR ATROPHY; PROTEIN EXPRESSION; RNA INTERFERENCE; STEM CELL; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; GENE SILENCING; HUMANS; MIDDLE AGED; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MYOSITIS, INCLUSION BODY; NF-KAPPA B; PERICYTES; POLYMYOSITIS; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; STEM CELLS; TUMOR NECROSIS FACTORS; YOUNG ADULT;

EID: 84859033280     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.12.027     Document Type: Article

References (39)

1. Y. Chicheportiche, P.R. Bourdon, H. Xu, Y.M. Hsu, H. Scott, C. Hession, I. Garcia, J.L. Browning TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis J Biol Chem 272 1997 32401 32410
2. J.A. Winkles The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting Nat Rev Drug Discov 7 2008 411 425
3. S.A. Marsters, J.P. Sheridan, R.M. Pitti, J. Brush, A. Goddard, A. Ashkenazi Identification of a ligand for the death-domain-containing receptor Apo3 Curr Biol 8 1998 525 528
4. S.R. Wiley, J.A. Winkles TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TWEAKR/Fn14 receptor Cytokine Growth Factor Rev 14 2003 241 249
5. S.A. Brown, A. Ghosh, J.A. Winkles Full-length, membrane-anchored TWEAK can function as a juxtacrine signalling molecule and activate the NF-kappaB pathway J Biol Chem 285 2010 17432 17441
6. R.L. Meighan-Mantha, D.K. Hsu, Y. Guo, S.A. Brown, S.L. Feng, K.A. Peifley, G.F. Alberts, N.G. Copeland, D.J. Gilbert, N.A. Jenkins, C.M. Richards, J.A. Winkles The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration J Biol Chem 274 1999 33166 33176
7. S.L. Feng, Y. Guo, V.M. Factor, S.S. Thorgeirsson, D.W. Bell, J.R. Testa, K.A. Peifley, J.A. Winkles The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas Am J Pathol 156 2000 1253 1261
8. C. Dogra, H. Changotra, S. Mohan, A. Kumar Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein J Biol Chem 281 2006 10327 10336
9. C. Dogra, H. Changotra, N. Wedhas, X. Qin, J.E. Wergedal, A. Kumar TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine FASEB J 21 2007 1857 1869
10. C. Dogra, S.L. Hall, N. Wedhas, T.A. Linkhart, A. Kumar Fibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes Evidence for TWEAK-independent functions of Fn14 during myogenesis J Biol Chem 282 2007 15000 15010
11. A. Mittal, S. Bhatnagar, A. Kumar, E. Lach-Trifilieff, S. Wauters, H. Li, D.Y. Makonchuk, D.J. Glass, A. Kumar The TWEAKFn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice J Cell Biol 188 2010 833 849
12. L.C. Burkly, J.S. Michaelson, K. Hahm, A. Jakubowski, T.S. Zheng TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease Cytokine 40 2007 1 16
13. M. Girgenrath, S. Weng, C.A. Kostek, B. Browning, M. Wang, S.A. Brown, J.A. Winkles, J.S. Michaelson, N. Allaire, P. Schneider, M.L. Scott, Y.M. Hsu, H. Yagita, R.A. Flavell, J.B. Miller, L.C. Burkly, T.S. Zheng TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration EMBO J 25 2006 5826 5839
14. A. Mittal, S. Bhatnagar, A. Kumar, P.K. Paul, S. Kuang, A. Kumar Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice Am J Pathol 177 2010 1732 1742
15. W.K. Engel, V. Askanas Inclusion-body myositis: clinical, diagnostic, and pathologic aspects Neurology 66 2 Suppl 1 2006 S20 S29
16. M. Needham, F.L. Mastaglia Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches Lancet Neurol 6 2007 620 631
17. V. Askanas, W.K. Engel Sporadic inclusion-body myositis: conformational multifactorial ageing-related degenerative muscle disease associated with proteasomal and lysosomal inhibition, endoplasmic reticulum stress, and accumulation of amyloid-β42 oligomers and phosphorylated tau Presse Med 40 4 Pt 2 2011 e219 e235
18. M.C. Dalakas Sporadic inclusion body myositis diagnosis, pathogenesis and therapeutic strategies Nat Clin Pract Neurol 2 2006 437 447
19. V. Askanas, W.K. Engel, A. Nogalska Inclusion body myositis: a degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation Brain Pathol 19 2009 493 506
20. M.C. Dalakas Immunotherapy of myositis: issues, concerns and future prospects Nat Rev Rheumatol 6 2010 129 137
21. R. Morosetti, M. Mirabella, C. Gliubizzi, A. Broccolini, L. De Angelis, E. Tagliafico, M. Sampaolesi, T. Gidaro, M. Papacci, E. Roncaglia, S. Rutella, S. Ferrari, P.A. Tonali, E. Ricci, G. Cossu MyoD expression restores defective myogenic differentiation of human mesangioblasts from inclusion-body myositis muscle Proc Natl Acad Sci USA 103 2006 16995 17000
22. D. Coletti, E. Yang, G. Marazzi, D. Sassoon TNFα inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways EMBO J 21 2002 631 642
23. C.C. Yang, V. Askanas, W.K. Engel, R.B. Alvarez Immunolocalization of transcription factor NF-kappa B in inclusion-body myositis muscle and at normal human neuromuscular junctions Neurosci Lett 254 2 1998 77 80
24. A. Nogalska, S. Wojcik, W.K. Engel, J. McFerrin, V. Askanas Endoplasmic reticulum stress induces myostatin precursor protein and NF-kappaB in cultured human muscle fibers: relevance to inclusion body myositis Exp Neurol 204 2 2007 610 618
25. A. Dellavalle, M. Sampaolesi, R. Tonlorenzi, E. Tagliafico, B. Sacchetti, L. Perani, A. Innocenzi, B.G. Galvez, G. Messina, R. Morosetti, S. Li, M. Belicchi, G. Peretti, J.S. Chamberlain, W.E. Wright, Y. Torrente, S. Ferrari, P. Bianco, G. Cossu Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells Nat Cell Biol 9 2007 255 267
26. T. Ando, J. Ichikawa, M. Wako, K. Hatsushika, Y. Watanabe, M. Sakuma, K. Tasaka, H. Ogawa, Y. Hamada, H. Yagita, A. Nakao TWEAK/Fn14 interaction regulates RANTES production BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells Arthritis Res Ther 8 2006 R146
27. S.J. Perper, B. Browning, L.C. Burkly, S. Weng, C. Gao, K. Giza, L. Su, L. Tarilonte, T. Crowell, L. Rajman, L. Runkel, M. Scott, G.J. Atkins, D.M. Findlay, T.S. Zheng, H. Hess TWEAK is a novel arthritogenic mediator J Immunol 177 2006 2610 2620
28. J.S. Duffield The inflammatory macrophage: a story of Jekyll and Hyde Clin Sci (Lond) 104 2003 27 38
29. F. Merly, L. Lescaudron, T. Rouaud, F. Crossin, M.F. Gardahaut Macrophages enhance muscle satellite cell proliferation and delay their differentiation Muscle Nerve 22 1999 724 732
30. M. Kumar, D.Y. Makonchuk, H. Li, A. Mittal, A. Kumar TNF-like weak inducer of apoptosis (TWEAK) activates proinflammatory signaling pathways and gene expression through the activation of TGF-beta-activated kinase 1 J Immunol 182 2009 2439 2448
31. Z.C. Liu, Q.L. Zhou, X.Z. Li, J.H. Yang, X. Ao, P. Veeraragoo, X.X. Zuo Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus Cytokine 53 2011 295 300
32. S. Desplat-Jégo, L. Feuillet, R. Creidy, I. Malikova, R. Rance, M. Khrestchatisky, K. Hahm, L.C. Burkly, J. Pelletier, J. Boucraut TWEAK is expressed at the cell surface of monocytes during multiple sclerosis J Leukoc Biol 85 2009 132 135
33. A.M. Mueller, X. Pedré, I. Kleiter, M. Hornberg, A. Steinbrecher, G. Giegerich Targeting fibroblast growth factor-inducible-14 signaling protects from chronic relapsing experimental autoimmune encephalomyelitis J Neuroimmunol 159 2005 55 65
34. R.C. Langen, A.M. Schols, M.C. Kelders, E.F. Wouters, Y.M. Janssen-Heininger Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappa B FASEB J 15 2001 1169 1180
35. R.C. Langen, J.L. Van Der Velden, A.M. Schols, M.C. Kelders, E.F. Wouters, Y.M. Janssen-Heininger Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization FASEB J 18 2004 227 237
36. A. Broccolini, T. Gidaro, R. Morosetti, C. Gliubizzi, T. Servidei, M. Pescatori, P.A. Tonali, E. Ricci, M. Mirabella Neprilysin participates in skeletal muscle regeneration and is accumulated in abnormal muscle fibres of inclusion body myositis J Neurochem 96 2006 777 789
37. A. Broccolini, E. Ricci, M. Pescatori, M. Papacci, C. Gliubizzi, A. D'Amico, S. Servidei, P.A. Tonali, M. Mirabella Insulin-like growth factor I in inclusion-body myositis and human muscle cultures J Neuropathol Exp Neurol 63 2004 650 659
38. H. Li, A. Mittal, P.K. Paul, M. Kumar, D.S. Srivastava, S.C. Tyagi, A. Kumar Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy J Biol Chem 284 2009 4439 4450
39. N.L. Tran, W.S. McDonough, B.A. Savitch, S.P. Fortin, J.A. Winkles, M. Symons, M. Nakada, H.E. Cunliffe, G. Hostetter, D.B. Hoelzinger, J.L. Rennert, J.S. Michaelson, L.C. Burkly, C.A. Lipinski, J.C. Loftus, L. Mariani, M.E. Berens Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappa B and correlate with poor patient outcome Cancer Res 66 2006 9535 9542